BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36466928)

  • 1. Perturbations of the T-cell immune repertoire in kidney transplant rejection.
    Sigdel TK; Fields PA; Liberto J; Damm I; Kerwin M; Hood J; Towfighi P; Sirota M; Robins HS; Sarwal MM
    Front Immunol; 2022; 13():1012042. PubMed ID: 36466928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
    Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
    BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples.
    Christakoudi S; Runglall M; Mobillo P; Tsui TL; Duff C; Domingo-Vila C; Kamra Y; Delaney F; Montero R; Spiridou A; Kassimatis T; Phin-Kon S; Tucker B; Farmer C; Strom TB; Lord GM; Rebollo-Mesa I; Stahl D; Sacks S; Hernandez-Fuentes MP; Chowdhury P
    EBioMedicine; 2019 Mar; 41():571-583. PubMed ID: 30833191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.
    Alachkar H; Mutonga M; Kato T; Kalluri S; Kakuta Y; Uemura M; Imamura R; Nonomura N; Vujjini V; Alasfar S; Rabb H; Nakamura Y; Alachkar N
    BMC Nephrol; 2016 Nov; 17(1):181. PubMed ID: 27871261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant Recipients.
    Aschauer C; Jelencsics K; Hu K; Gregorich M; Reindl-Schwaighofer R; Wenda S; Wekerle T; Heinzel A; Oberbauer R
    Front Immunol; 2022; 13():843452. PubMed ID: 35281040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation.
    Stranavova L; Pelak O; Svaton M; Hruba P; Fronkova E; Slavcev A; Osickova K; Maluskova J; Hubacek P; Fronek J; Reinke P; Volk HD; Kalina T; Viklicky O
    Front Immunol; 2019; 10():2549. PubMed ID: 31736968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts.
    Aschauer C; Jelencsics K; Hu K; Heinzel A; Gregorich MG; Vetter J; Schaller S; Winkler SM; Weinberger J; Pimenov L; Gualdoni GA; Eder M; Kainz A; Troescher AR; Regele H; Reindl-Schwaighofer R; Wekerle T; Huppa JB; Sykes M; Oberbauer R
    Front Immunol; 2021; 12():750005. PubMed ID: 34721420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor repertoires within liver allografts are different to those in the peripheral blood.
    Mederacke YS; Nienen M; Jarek M; Geffers R; Hupa-Breier K; Babel N; Reinke P; Mederacke I; Vondran FWR; Jonigk D; Wedemeyer H; Jaeckel E
    J Hepatol; 2021 May; 74(5):1167-1175. PubMed ID: 33347951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of immune repertoire sequencing in solid organ transplant.
    Wong P; Cina DP; Sherwood KR; Fenninger F; Sapir-Pichhadze R; Polychronakos C; Lan J; Keown PA
    Front Immunol; 2023; 14():1100479. PubMed ID: 36865546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.
    Niu Q; Mendoza Rojas A; Dieterich M; Roelen DL; Clahsen-van Groningen MC; Wang L; van Gelder T; Hesselink DA; van Besouw NM; Baan CC
    Front Immunol; 2020; 11():1972. PubMed ID: 32983131
    [No Abstract]   [Full Text] [Related]  

  • 13. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.
    Žilinská Z; Bandžuchová H; Chrastina M; Trebatický B; Breza J; Handzušová M; Kuba D; Tirpáková J; Pavlechová M; Dedinská I; Rychlý B; Poláková K
    Transpl Immunol; 2015 Nov; 33(3):159-65. PubMed ID: 26455418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
    Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
    PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant.
    Park WY; Paek JH; Jin K; Park SB; Choe M; Han S
    Transplant Proc; 2019 Oct; 51(8):2655-2659. PubMed ID: 31345597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
    Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
    Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.